Anurag S. Rathore

The implementation of Industry 4.0 is projected to save time and cost for designing an optimal manufacturing process.

Therapeutic protein aggregates can be characterized using image analysis algorithms coupled with microscopy techniques.

Image analysis algorithms coupled with microscopy techniques can be used to characterize aggregates of therapeutic proteins.

Image analysis algorithms coupled with microscopy techniques can be used to characterize aggregates of therapeutic proteins.

A novel mathematical approach for fitting concentration-response curves is proposed that offers a more accurate estimation of potency data.

This article summarizes industry views on PAT in bioprocess-related applications and presents a vision for the biopharmaceutical industry to achieve Industry 4.0.

The authors review some of the monoclonal antibody candidates that reached Phase III clinical trials but were discontinued at later stages.

The authors review some of the monoclonal antibody candidates that reached Phase III clinical trials but were discontinued at later stages.

The biopharmaceutical landscape of India is transforming in terms of regulatory policies, product development, and affordability.

The need for real-time monitoring and control has spurred the development of new analytical tools.